Stay updated on Abemaciclib and Nivolumab for HCC Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib and Nivolumab for HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib and Nivolumab for HCC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s footer software release/revision indicator was updated from v3.5.2 to v3.5.3, reflecting a site/UI version change without altering the study information displayed.
    Difference
    0.1%
    Check dated 2026-04-24T22:44:30.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:18:03.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Hepatocellular carcinoma is now listed as the study condition and a Genetics and Rare Diseases Information Center resource link was added under Resources; the page revision updated from 3.4.3 to 3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T23:48:35.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The site revision was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:23:45.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Revision: v3.4.2 appears, replacing Revision: v3.4.1. This is a minor update to the page's version label.
    Difference
    0.1%
    Check dated 2026-02-12T01:46:18.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1, replacing the prior Revision: v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-04T23:31:06.000Z thumbnail image

Stay in the know with updates to Abemaciclib and Nivolumab for HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib and Nivolumab for HCC Clinical Trial page.